NUMD Stock Overview
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Nu-Med Plus, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.067 |
| 52 Week High | US$0.09 |
| 52 Week Low | US$0.009 |
| Beta | 0.96 |
| 1 Month Change | 47.78% |
| 3 Month Change | 216.67% |
| 1 Year Change | 411.54% |
| 3 Year Change | -77.83% |
| 5 Year Change | -91.13% |
| Change since IPO | -91.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| NUMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 52.3% | 1.4% | 1.2% |
| 1Y | 411.5% | -0.7% | 24.7% |
Return vs Industry: NUMD exceeded the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: NUMD exceeded the US Market which returned 19.3% over the past year.
Price Volatility
| NUMD volatility | |
|---|---|
| NUMD Average Weekly Movement | 54.6% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NUMD's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine NUMD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 2 | Bill Hayde | www.nu-medplus.com |
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. The company develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. It serves hospitals, health systems, and the medical community.
Nu-Med Plus, Inc. Fundamentals Summary
| NUMD fundamental statistics | |
|---|---|
| Market cap | US$5.56m |
| Earnings (TTM) | -US$125.53k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-44.3x
P/E RatioIs NUMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NUMD income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$125.53k |
| Earnings | -US$125.53k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0015 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -68.1% |
How did NUMD perform over the long term?
See historical performance and comparison